C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/22 (2006.01) A61K 31/405 (2006.01) A61K 31/41 (2006.01) A61K 31/44 (2006.01) A61K 31/495 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) A61K 31/55 (2006.01) C07D 401/12 (2006.01) C07D 403/06 (2006.01) C07D 413/06 (2006.01) C07D 417/06 (2006.01)
Patent
CA 2219111
The invention encompasses the novel compound of Formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutcial compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula (I).
L'invention concerne le nouveau composé selon la formule (I), ainsi qu'un procédé de traitement des maladies provoquées par la cyclooxygénase-2, consistant à administrer à un patient nécessitant un traitement non toxique de ce type une dose thérapeutiquement efficace d'un composé selon la formule (I). L'invention traite également de certaines compositions pharmaceutiques pour le traitement des maladies provoquées par la cyclooxygénase-2, comprenant les composés de la formule (I).
Black Cameron
Ducharme Yves
Gauthier Jacques-Yves
Guay Daniel
Hamel Pierre
Merck Frosst Canada Inc.
Ogilvy Renault
LandOfFree
N-benzylindol-3-yl propanic acid derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-benzylindol-3-yl propanic acid derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-benzylindol-3-yl propanic acid derivatives as... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2000263